Efficacy of blood plasma spectroscopy for early liver cancer diagnostics in obese patients

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22340%2F24%3A43930791" target="_blank" >RIV/60461373:22340/24:43930791 - isvavai.cz</a>

Alternative codes found

RIV/60162694:G44__/25:00563506 RIV/00216208:11110/24:10482217 RIV/61383082:_____/24:00001430

Result on the web

<a href="https://www.elsevier.es/es-revista-annals-hepatology-16-articulo-efficacy-blood-plasma-spectroscopy-for-S1665268124003132" target="_blank" >https://www.elsevier.es/es-revista-annals-hepatology-16-articulo-efficacy-blood-plasma-spectroscopy-for-S1665268124003132</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.aohep.2024.101519" target="_blank" >10.1016/j.aohep.2024.101519</a>

Result language

angličtina

Original language name

Efficacy of blood plasma spectroscopy for early liver cancer diagnostics in obese patients

Original language description

Hepatocellular carcinoma (HCC) represents one of the most common cancers worldwide. A considerable proportion of HCC is caused by cirrhosis related to metabolic dysfunction-associated steatohepatitis (MASH). Due to the increasing prevalence of metabolic syndrome, it is estimated that MASH-related HCC will become the most prevalent etiology of HCC. Currently, HCC screening is based on liver ultrasonography; however, the sensitivity of ultrasonography for early HCC stages in obese patients only reaches 23 %. To date, no studied biomarker shows sufficient efficacy for screening purposes. Nevertheless, the usage of spectroscopic methods offers a new perspective, as its potential use would provide cheap, fast analysis of samples such as blood plasma.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

10406 - Analytical chemistry

Project

<a href="/en/project/NV19-08-00525" target="_blank" >NV19-08-00525: Early diagnostics of hepatocellular carcinoma in patients with liver cirrhosis by novel molecular spectrometric biomarkers in blood plasma</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2024

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Annals of Hepatology

ISSN

1665-2681

e-ISSN

—

Volume of the periodical

29

Issue of the periodical within the volume

5

Country of publishing house

MX - MEXICO

Number of pages

6

Pages from-to

—

UT code for WoS article

001262729100001

EID of the result in the Scopus database

2-s2.0-85196409377